Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1035 of 1,261

  1. US 7528133

    Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation

    The Board of Regents of the University of Texas System · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  2. US 7528138

    Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  3. US 7527934

    Labeled substrate conjugates for identifying enzyme inhibitors

    The Regents of the University of California · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  4. US 7527802

    Vaccine for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  5. AR 064864

    COMPUESTOS ANALOGOS DE PIRIDINA VII 543 Y COMPOSICION FARMACEUTICA

    ASTRAZENECA AB [SE] · Granted Apr 29, 2009 · Expires Apr 24, 2029

    granted

  6. US 7524944

    Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α

    The Regents of the University of California · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  7. US 7524490

    Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

    The Board of Regents of the University of Texas System · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  8. US 7524959

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  9. US 7524965

    Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  10. US 7524962

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  11. US 7524507

    Recombinant microorganisms

    The Secretary of State for Defence in Her Brittanic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  12. US 7524880

    Crystalline form of a substituted pyrrolidine compound

    Theravance, Inc. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  13. US 7524878

    Phenyl substituted carboxylic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  14. US 7524516

    Corrosion inhibiting mildew remover kit

    United States of America as represented by the Secretary of the Air Force · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  15. US 7524508

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  16. US 7524499

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  17. CA 2702664

    FORMULATION PHARMACEUTIQUE A LIBERATION CONTROLEE

    ALPHAPHARM PTY LTD [AU] · Granted Apr 23, 2009 · Expires Apr 18, 2029

    granted

  18. US 7521421

    Deuterated cyclosporine analogs and methods of making the same

    Isotechnika, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  19. US 7521551

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  20. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  21. US 7521535

    Anti-microbial defensin-related peptides and methods of use

    The Board of Regents for Oklahoma State University · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  22. US 7521545

    Azo compounds and process for production thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  23. US 7521479

    Methods of treating prion disease in mammals

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  24. US 7521192

    EDG: modulators of lymphocyte activation and migration

    Rigel Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.